Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer Reliability of Restaging With Combined Positron Emission Tomography and Computed Tomography

被引:33
|
作者
Malone, James P. [1 ]
Gerberi, Michael A. T. [1 ]
Vasireddy, Syam [2 ,4 ]
Hughes, Larry F. [1 ]
Rao, Krishna [3 ]
Shevlin, Bruce [5 ]
Kuhn, Matthew [2 ,4 ]
Collette, Dean [2 ,4 ]
Tennenhouse, Joel [2 ,4 ]
Robbins, K. Thomas [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Radiol, Springfield, IL 62794 USA
[3] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA
[4] St Johns Hosp, Dept Radiol, Springfield, IL USA
[5] St Johns Hosp, Dept Radiat Oncol, Springfield, IL USA
关键词
SQUAMOUS-CELL CARCINOMA; STAGE-IV HEAD; RADIATION-THERAPY; FOLLOW-UP; FDG PET; DISSECTION; CHEMORADIATION; RADIOTHERAPY; UTILITY; CT;
D O I
10.1001/archoto.2009.152
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To assess the role of combined positron emission tomography and computed tomography (PET-CT) in predicting early treatment response at the primary site and in the neck after chemoradiotherapy (CRT) for advanced squamous cell carcinoma of the head and neck (SCCHN). Design: Retrospective analysis with a median follow-up of 24 months. Setting: Academic, tertiary referral center. Patients and Interventions: Thirty-one patients who were treated with concomitant intra-arterial CRT underwent PET-CT 6 to 8 weeks after the completion of treatment. Patients with findings on the physical examination, CT, or PET-CT indicative of persistent disease underwent appropriate surgical intervention for pathological assessment. Patients with a complete clinical response were observed with routine follow-up physical examination for disease recurrence. No evidence of disease at least 6 months after the completion of PET-CT was considered confirmation of complete clinical response. Main Outcome Measures: Presence or absence of residual or recurrent disease during the follow-up period was used to calculate the sensitivity, specificity, and positive and negative predictive values of PET-CT for the primary site and the neck. Results: Assessment of tumor response at the primary site with PET-CT had a sensitivity, specificity, and positive and negative predictive values of 83%, 54%, 31%, and 92%, respectively. In patients with pretreatment N1 to N3 disease, the sensitivity, specificity, and positive and negative predictive values of posttreatment PET-CT were 75%, more than 94%, more than 75%, and 94%, respectively, and the specificity and negative predictive value for patients with pretreatment N0 disease in the neck were 92% and more than 92%, respectively. Conclusions: Negative PET-CT findings accurately determine early disease response at the primary site and in the neck. False-positive findings are common at the primary site. Patients with a negative PET-CT finding after the completion of intra-arterial CRT do not require surgical intervention.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 50 条
  • [21] Positron Emission Tomography/Computed Tomography in Evaluation of the Clinically NO Neck in Head and Neck Squamous Cell Carcinoma
    Ferris, Robert L.
    Cramer, John D.
    Branstetter, Barton F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (20) : 1683 - +
  • [22] ACCURACY OF POSITRON EMISSION TOMOGRAPHY IN THE EVALUATION OF PATIENTS TREATED WITH CHEMORADIOTHERAPY FOR MUCOSAL HEAD AND NECK CANCER
    Martin, Richard C. W.
    Fulham, Michael
    Shannon, Kerwin F.
    Hughes, Ceri
    Gao, Kan
    Milross, Chris
    Tin, Mo Mo
    Jackson, Michael
    Clifford, Anthony
    Boyer, Michael J.
    O'Brien, Christopher J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (02): : 244 - 250
  • [23] The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy
    Cerfolio, RJ
    Bryant, AS
    Ohja, B
    Bartolucci, AA
    Eloubeidi, MA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (06): : 1232 - 1241
  • [24] Comparison of Positron Emission Tomography/Computed Tomography Imaging and Ultrasound in Staging and Surveillance of Head and Neck and Thyroid Cancer
    Hwang, Harry S.
    Perez, Daniel A.
    Orloff, Lisa A.
    LARYNGOSCOPE, 2009, 119 (10): : 1958 - 1965
  • [25] Positron Emission Tomography-Computed Tomography Surveillance for the Node-Positive Neck After Chemoradiotherapy
    Rabalais, Amy G.
    Walvekar, Rohan
    Nuss, Daniel
    McWhorter, Andrew
    Wood, Charles
    Fields, Robert
    Mercante, Donald E.
    Pou, Anna M.
    LARYNGOSCOPE, 2009, 119 (06): : 1120 - 1124
  • [26] THE ROLE OF COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF THE NECK FOLLOWING CHEMORADIOTHERAPY FOR HEAD AND NECK CANCER
    Clavel, S.
    Charron, M. P.
    Belair, M.
    Delouya, G.
    Fortin, B.
    Despres, P.
    Soulieres, D.
    Filion, E.
    Guertin, L.
    Nguyen-Tan, P. F.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S84 - S84
  • [27] Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer
    Zimmer, LA
    McCook, B
    Meltzer, C
    Fukui, M
    Bascom, D
    Snyderman, C
    Townsend, DW
    Johnson, JT
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 128 (02) : 178 - 184
  • [28] The use of positron emission tomography and computed tomography in the assessment of trismus associated with head and neck malignancy
    Tierney, PA
    Farag, I
    Saunders, CAB
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1998, 112 (03): : 303 - 306
  • [29] Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers
    Awan, Musaddiq J.
    Siddiqui, Farzan
    Schwartz, David
    Yuan, Jiankui
    Machtay, Mitchell
    Yao, Min
    WORLD JOURNAL OF RADIOLOGY, 2015, 7 (11): : 382 - 393
  • [30] Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers
    Menda, Y
    Graham, MM
    SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (04) : 214 - 219